Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Pocock

Showing results (71-80 of 349) with videos related to

Pageof 35
Sort By:
Journal of the American College of Cardiology|January 18, 2005
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3)Joseph Kim, Robert A Henderson, Stuart J Pocock, et al.
Journal of Clinical Epidemiology|March 4, 2008
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
Revista Espanola De Salud Publica|August 20, 2008
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]Erik von Elm, Douglas G Altman, Matthias Egger, et al.
American Heart Journal|March 20, 2012
Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialGregg W Stone, Tim C Clayton, Roxana Mehran, et al.
International Journal of Surgery (London, England)|July 22, 2014
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
Journal of the American College of Cardiology|September 4, 2024
Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?John Gregson, Stuart J Pocock, Stefan D Anker, et al.
European Journal of Heart Failure|January 6, 2022
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trialJaved Butler, Tariq Jamal Siddiqi, Gerasimos Filippatos, et al.
Journal of the American College of Cardiology|May 20, 2017
Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?Markus C Elze, John Gregson, Usman Baber, et al.
Current Vascular Pharmacology|December 28, 2018
Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR StudyJanina Stepinska, Izabela Wojtkowska, Lieven Annemans, et al.
Journal of the American College of Cardiology|February 11, 2026
Extension Reports in Clinical Trials: A Systematic Review and Consequent GuidanceXavier Rossello, Stuart J Pocock, Dylan Taylor, et al.
Pageof 35

Showing results (71-80 of 349) with videos related to

Sort By:
Pageof 35
Journal of the American College of Cardiology|January 18, 2005
Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3)Joseph Kim, Robert A Henderson, Stuart J Pocock, et al.
Journal of Clinical Epidemiology|March 4, 2008
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
Revista Espanola De Salud Publica|August 20, 2008
[The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]Erik von Elm, Douglas G Altman, Matthias Egger, et al.
American Heart Journal|March 20, 2012
Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trialGregg W Stone, Tim C Clayton, Roxana Mehran, et al.
International Journal of Surgery (London, England)|July 22, 2014
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studiesErik von Elm, Douglas G Altman, Matthias Egger, et al.
Journal of the American College of Cardiology|September 4, 2024
Competing Risks in Clinical Trials: Do They Matter and How Should We Account for Them?John Gregson, Stuart J Pocock, Stefan D Anker, et al.
European Journal of Heart Failure|January 6, 2022
Early benefit with empagliflozin in heart failure with preserved ejection fraction: insights from the EMPEROR-Preserved trialJaved Butler, Tariq Jamal Siddiqi, Gerasimos Filippatos, et al.
Journal of the American College of Cardiology|May 20, 2017
Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?Markus C Elze, John Gregson, Usman Baber, et al.
Current Vascular Pharmacology|December 28, 2018
Long-Term Outcome of Acute Coronary Syndromes in Patients on Chronic Oral Anticoagulants: Data from the EPICOR StudyJanina Stepinska, Izabela Wojtkowska, Lieven Annemans, et al.
Journal of the American College of Cardiology|February 11, 2026
Extension Reports in Clinical Trials: A Systematic Review and Consequent GuidanceXavier Rossello, Stuart J Pocock, Dylan Taylor, et al.
Pageof 35